ASCO Guideline Update: Use of Endocrine Therapy for Breast Cancer Risk Reduction
On September 3, 2019, ASCO posted the "Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline Update". The decision regarding choice of endocrine therapy should take into consideration age, baseline comorbidities, and adverse effect profiles. Slides, a recommendations table, decision aid, patient information, pocketcard, and visual abstract are available. There is also a podcast interview with panel members.